EUVIMEDEUVIMED entdecken
Crossref

Biogenetic Vesicle‐Based Cancer Vaccines with Tunable Surface Potential and Immune Potency

Hao Qin, Hejia Li, Jin Zhu, Yuting Qin, Nan Li, Jian Shi, Guangjun Nie iD, Ruifang Zhao

Small · 2023

DOI: 10.1002/smll.202303225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von Hao Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience a…. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer vaccines are designed to motivate antigen‐specific immune responses and facilitate tumor regression with minimal side effects. To fully exert the potential of vaccines, rationally designed formulations that effectively deliver antigens and trigger potent immune reactions are urgently needed. This study demonstrates a simple and controllable vaccine‐developing strategy that assembles tumor antigens into bacterial outer membrane vesicles (OMVs), natural delivery vehicles with intrinsic immune adjuvant properties, via electrostatic interaction. This OMV‐delivered vaccine (OMVax) stimulated both innate and adaptive immune responses, leading to enhanced metastasis inhibition and prolonged survival of tumor‐bearing mice. Moreover, the influence of different surface charged OMVax on antitumor immunity activation is investigated and declined immune response activation occurred with increased positive surface charge. Together, these findings suggest a simple vaccine formulation that can be enhanced by optimizing the surface charges of vaccine formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesNeoplasmsAnimalsMiceAntigensAdjuvants, Immunologic

Stichwörter der Autor:innen

cancer vaccinesimmunotherapynanotechnologyouter membrane vesicles (OMVs)

Substanzen

Cancer VaccinesAntigensAdjuvants, Immunologic

Autor:innen und Institutionen

  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, P. R. China.
  • Third Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomate…
  • Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

ORCID-Profile: Guangjun Nie

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qin, H., Li, H., Zhu, J., Qin, Y., Li, N., Shi, J., Nie, G., & Zhao, R. (2023). Biogenetic Vesicle‐Based Cancer Vaccines with Tunable Surface Potential and Immune Potency. Small. https://doi.org/10.1002/smll.202303225

Vancouver

Qin H, Li H, Zhu J, Qin Y, Li N, Shi J, et al. Biogenetic Vesicle‐Based Cancer Vaccines with Tunable Surface Potential and Immune Potency. Small. 2023. doi:10.1002/smll.202303225

BibTeX
@article{Qin2023,
  author = {Qin, Hao and Li, Hejia and Zhu, Jin and Qin, Yuting and Li, Nan and Shi, Jian and Nie, Guangjun and Zhao, Ruifang},
  title = {Biogenetic Vesicle‐Based Cancer Vaccines with Tunable Surface Potential and Immune Potency},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202303225}
}
Kostenlos starten →